JOSEPH REXROAT: Open Payments
NPI 1699126102 · TRAVERSE CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$365 in 17 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $51 · 2025 $365
Food & beverage: $365
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $66 |
| Amgen Inc. | 2 | $53 |
| Astellas Pharma US Inc | 2 | $49 |
| Corium, LLC | 1 | $26 |
| Exact Sciences Corporation | 1 | $26 |
| Indivior Inc. | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| PFIZER INC. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: Veozah, EVENITY, Azstarys, Cologuard Collection Kit, SUBLOCADE, Wegovy, Ozempic, INGREZZA.
Industry payments across MI — which companies pay providers there.
